Search

Your search keyword '"Santoro M.M."' showing total 87 results

Search Constraints

Start Over You searched for: Author "Santoro M.M." Remove constraint Author: "Santoro M.M."
87 results on '"Santoro M.M."'

Search Results

1. Partially folded intermediates during trypsinogen denaturation

2. Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals

Catalog

Books, media, physical & digital resources

11. Advantages and challenges of cardiovascular and lymphatic studies in zebrafish research

12. Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients

14. The effect of organic solvents and other parameters on trypsin-catalyzed hydrolysis of N(subscript a)-benzoyl-arginine-p-nitroanilide

16. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

17. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus

18. Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration

20. P0915 : Clinical relevance of baseline/early detection and persistence of resistant associated variants in HCV-1 patients treated with protease-inhibitors assessed by ultra-deep sequencing

21. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus

22. Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors

23. Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis

24. The effect of laboratory maintenance of Panstrongylus megistus on its flight activity

41. Key genetic markers in the full-length HBsAg gene correlate with HBV-driven carcinogenesis by affecting HBsAg secretion and release

45. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

46. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

47. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

48. Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors

49. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

50. Evaluation of HIV transmission clusters among natives and foreigners living in Italy